A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 4, 2001, Pages 352-357

  McKee, G T ^a   Tambouret, R H ^a   Finkelstein, D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cytology; Estrogen receptor; Fluorescence in situ hybridization; HER 2 neu; Immunohistochemistry; Progesterone receptor

Indexed keywords

ALCOHOL; ESTROGEN RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; RECEPTOR, ERBB 2;

ACCURACY; ARTICLE; BREAST CARCINOMA; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE NEU; PRIORITY JOURNAL; TECHNIQUE; TISSUE FIXATION; BREAST TUMOR; CHEMISTRY; COMPARATIVE STUDY; FEMALE; METHODOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; STANDARD;

BREAST NEOPLASMS; COMPARATIVE STUDY; CYTOLOGICAL TECHNIQUES; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 0035200378     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200112000-00011     Document Type: Article

References (31)

1. Prognostic predictive factors
2. Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
3. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
4. Estrogen receptor status by immunohistochemistry is superior to the ligand binding assay for predicting response to adjuvant endocrine therapy in breast cancer
5. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
6. C-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
7. Neu/CerbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
8. HER-2/neu (c-erbB-2) gene and protein in breast cancer
9. Efficacy and safety of Herceptin® (humanized anti-human HER-2 antibody) as a single agent in 222 women with HER-2 overexpression who relapsed following chemotherapy for metastatic breast cancer
10. C-erbB-2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
11. Prognostic factors in breast cancer
12. The stability of estrogen and progesterone in patients receiving chemotherapy for locally advanced breast carcinoma
13. Estrogen and progesterone receptors in breast cancer. Immunohistochemical assay on scraping material
14. Demonstration of oestrogen receptor in symptomatic breast carcinoma, using fine needle aspiration cytology
15. Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates
16. Semiquantitative assessment of c-erbB-2 (HER-2) status in cytology specimens and tissue sections from breast carcinoma
17. Progesterone-receptor assay in fine needle aspirates of breast tumors
18. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: Correlation with paraffin embedded and frozen sections determinations
19. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients
20. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study
21. Comparison of four immunochemical methods for the measurement of oestrogen receptor levels in breast cancer
22. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay
23. Estrogen an progesterone receptor status determined by the Ventana ER 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: Prognostic significance
24. Computer-assisted immunocytochemical determination of breast cancer steroid receptors on cytological smears of excised surgical specimens compared with frozen sections
25. Comparison of immunoreactivity of neu oncoprotein in fine-needle aspirates and paraffin-embedded material
26. Immunocytochemical staining of c-erbB-2 oncogene in fine-needle aspirates of breast carcinoma: A comparison with tissue sections and other breast cancer prognostic factors
27. Retrospective c-erbB-2 immunostaining in aspiration cytology of breast cancer
28. Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples
29. Fluorescence in situ hybridization (FISH): A user's guide to optimal preparation of cytologic specimens
30. If cells could talk. The application of new techniques to cytopathology